1
Clinical Trials associated with Factor VIII(Wuhan Zhongyuan Ruide Biological Products)评价人凝血因子Ⅷ治疗甲型血友病患者的疗效及安全性的多中心、单臂、开放性临床研究
[Translation] A multicenter, single-arm, open-label clinical study to evaluate the efficacy and safety of human coagulation factor VIII in the treatment of patients with hemophilia A
本临床试验的主要目的是评价武汉中原瑞德生物制品有限责任公司生产的人凝血因子Ⅷ治疗甲型血友病患者的有效性和安全性
[Translation] The main purpose of this clinical trial is to evaluate the efficacy and safety of human coagulation factor VIII produced by Wuhan Zhongyuan Ruide Biological Products Co., Ltd. in the treatment of hemophilia A patients.
100 Clinical Results associated with Factor VIII(Wuhan Zhongyuan Ruide Biological Products)
100 Translational Medicine associated with Factor VIII(Wuhan Zhongyuan Ruide Biological Products)
100 Patents (Medical) associated with Factor VIII(Wuhan Zhongyuan Ruide Biological Products)
100 Deals associated with Factor VIII(Wuhan Zhongyuan Ruide Biological Products)